|
gptkbp:instance_of
|
gptkb:chemical_compound
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:artemisinin
|
|
gptkbp:appointed_by
|
oral tablets
intravenous form
rectal form
|
|
gptkbp:can_be_used_with
|
gptkb:lumefantrine
gptkb:mefloquine
gptkb:piperaquine
|
|
gptkbp:class
|
sesquiterpene lactones
|
|
gptkbp:composed_of
|
artemisinic acid
|
|
gptkbp:developed_by
|
gptkb:Artemisia_annua
gptkb:sweet_wormwood
|
|
gptkbp:discovered_by
|
gptkb:Tu_Youyou
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Artemisinin
|
|
gptkbp:ingredients
|
C15 H22 O5
|
|
gptkbp:is_affected_by
|
gptkb:theorem
|
|
gptkbp:is_considered
|
a breakthrough in malaria treatment
|
|
gptkbp:is_effective_against
|
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_vivax
|
|
gptkbp:is_known_for
|
rapid action against malaria parasites
|
|
gptkbp:is_part_of
|
gptkb:WHO_Essential_Medicines_List
artemisinin-based combination therapies (AC Ts)
|
|
gptkbp:is_studied_in
|
gptkb:healthcare_organization
viral infections
|
|
gptkbp:is_subject_to
|
resistance development
|
|
gptkbp:is_used_for
|
treating malaria
|
|
gptkbp:is_used_in
|
gptkb:product
|
|
gptkbp:produced_by
|
biotechnological methods
|
|
gptkbp:regulates
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:replaced_by
|
gptkb:1972
|
|
gptkbp:research
|
pharmacokinetics
clinical trials
treatment efficacy
global health initiatives
treatment protocols
dosage optimization
pharmacodynamics
combination therapies
public health impact
treatment guidelines
safety profiles
new drug formulations
malaria eradication efforts
antimalarial drug resistance
|
|
gptkbp:side_effect
|
nausea
vomiting
diarrhea
|